Literature DB >> 1446251

Use of mesothelial cell cultures to assess the carcinogenic potency of mineral or man made fibers.

A Renier1, M Yegles, A Buard, H Dong, L Kheuang, L Saint-Etienne, P Laurent, M C Jaurand.   

Abstract

Natural mineral fibers may produce pulmonary cancers and mesothelioma. In contrast with lung cancer, the incidence of fiber-induced mesothelioma is not enhanced in smokers compared to non smokers. It is therefore of special interest to use mesothelial cells to study the toxicity of natural or man made mineral fibers. Several years ago, we have developed a method to culture rat pleural mesothelial cells (RPMC). We have first studied the effects of asbestos fibers by the application of in vitro tests formerly developed to determine the genotoxicity and transforming potency of soluble xenobiotics. Moreover, we have determined whether RPMC expressed cytochromes P450 known to metabolize polycyclic aromatic hydrocarbons. This paper reviews the results obtained so far. It has been found that asbestos fibers produced a cell transformation and a genotoxicity characterized by the formation of aneuploid cells, abnormal anaphases, chromosomal aberrations and DNA repair (UDS). In addition, RPMC expressed different forms of cytochromes P450. It is nowadays suggested that the tumorigenic potency of asbestos fibers may be related to the fiber dimensions, to their surface properties and in vivo biopersistence; this term involves the fiber solubility in biological medium and the fiber epuration from the lung by clearance mechanisms. Experiments are now in progress to determine whether the in vitro effects are dependent on the fiber parameters suggested as playing a role in the carcinogenic potency.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1446251     DOI: 10.1007/bf00130520

Source DB:  PubMed          Journal:  Cell Biol Toxicol        ISSN: 0742-2091            Impact factor:   6.691


  28 in total

1.  Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province.

Authors:  J C WAGNER; C A SLEGGS; P MARCHAND
Journal:  Br J Ind Med       Date:  1960-10

2.  Asbestos-associated chromosomal changes in human mesothelial cells.

Authors:  J F Lechner; T Tokiwa; M LaVeck; W F Benedict; S Banks-Schlegel; H Yeager; A Banerjee; C C Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

Review 3.  Man-made mineral fibres.

Authors: 
Journal:  IARC Monogr Eval Carcinog Risks Hum       Date:  1988

4.  In vitro assays for detecting carcinogenic mineral fibres: a comparison of two assays and the role of fibre size.

Authors:  G M Brown; H Cowie; J M Davis; K Donaldson
Journal:  Carcinogenesis       Date:  1986-12       Impact factor: 4.944

5.  Induction by asbestos fibers of anaphase abnormalities: mechanism for aneuploidy induction and possibly carcinogenesis.

Authors:  T W Hesterberg; J C Barrett
Journal:  Carcinogenesis       Date:  1985-03       Impact factor: 4.944

6.  Chromosomal changes induced by chrysotile fibres or benzo-3,4-pyrene in rat pleural mesothelial cells.

Authors:  M C Jaurand; L Kheuang; L Magne; J Bignon
Journal:  Mutat Res       Date:  1986-03       Impact factor: 2.433

7.  The interaction of asbestos and neutrophils injures cultured human pulmonary epithelial cells: role of hydrogen peroxide.

Authors:  D W Kamp; M Dunne; S A Weitzman; M M Dunn
Journal:  J Lab Clin Med       Date:  1989-11

8.  Dependence of asbestos- and mineral dust-induced transformation of mammalian cells in culture on fiber dimension.

Authors:  T W Hesterberg; J C Barrett
Journal:  Cancer Res       Date:  1984-05       Impact factor: 12.701

9.  Carcinogenicity studies on fibres, metal compounds, and some other dusts in rats.

Authors:  F Pott; U Ziem; F J Reiffer; F Huth; H Ernst; U Mohr
Journal:  Exp Pathol       Date:  1987

10.  Mesothelioma in rats following intrapleural injection of chrysotile and phosphorylated chrysotile (chrysophosphate).

Authors:  A Van der Meeren; J Fleury; M Nebut; G Monchaux; X Janson; M C Jaurand
Journal:  Int J Cancer       Date:  1992-04-01       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.